Analyst Ratings for Zenas Biopharma (ZBIO)
ZBIO Rating Summary
ZBIO Price Target Summary
- Highest: $48.00 (Jefferies)
- Lowest: $19.00 (Morgan Stanley)
- Average: $38.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$38.50 (+52.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$38.50 (+52.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Morgan Stanley | Sean Laaman | Downgrade | Equalweight (Overweight) |
19.00 (37.00) |
34.50 (25.28) |
-26.72% | Details |
| 3/20/2025 | Wedbush | Martin Fan | New Coverage | Outperform (N/A) |
35.00 (N/A) |
8.25 (25.28) |
206.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
